CClinicalTrials.gg
Status unknownNCT02857439CASHUpdated Aug 5, 2016

Creating a Diagnostic Decision Rule for Shoulder Injury: CASH-trial

An interventional study of Standard diagnostic item list in Trauma, sponsored by Zaans Medisch Centrum. Status unknown at 1 site in Netherlands. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2016-08-05.

Sponsored by Zaans Medisch Centrum · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Aug 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
280
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

What combination of ≤ 6 clinical variables will give the highest specificity for indicating significant shoulder injuries (fractures or dislocations) with a set sensitivity of ≥ 97%?

Although shoulder trauma is a common injury, there is no clinical decision rule to determine the necessity for radiography for these traumas. With this trial the investigators aim to develop such a rule to reduce the amount of radiographs without missing any significant injuries.

The primary objective is to compose a set of clinical diagnostic criteria predictive of shoulder fractures or dislocations that would reduce the amount of radiographs without missing any significant injuries. A second objective is to determine if the clinical decision rule is applicable for triage use.

Read the detailed description

The CASH (Clavicle-AC-Joint-Sub-capital-Humerus) trial is designed as a cross sectional interobserver study. It will randomize between first examiner of the patient to determine applicability for triage use and use a list of 19 criteria to determine a clinical decision rule for significant shoulder injuries.

Method/intervention After admittance to the ED, all consecutive shoulder injury patients will be assessed for eligibility in the study. After informed consent is given, the patient will be randomized for first observer (ED physician or triage nurse) to be examined, which means they will be assessed in duplo.

The patient will be examined by means of a score form, which contains 19 different diagnostic criteria. The criteria are grouped: anamnesis, inspection, palpation and pain/range of motion(ROM). After completing the list, patients will get a full set of shoulder x-rays: shoulder AP- and axial-view, and clavicle AP and 30' cranio-caudal view.

The trial participation for the patient will be completed at this point and final diagnosis and treatment are provided by the ED physician according to his/her own findings and interpretation of the radiographs. For the study, the radiographs will be reassessed by one consultant radiologist specialized in skeletal trauma.

02

Conditions studied

  • Trauma

Browse trials for

Keywords

  • Trauma of the shoulder
03

In context

Shoulder Injuries

114 studies on the registry are indexed under Shoulder Injuries; 31 are open to participants now.

This study's planned enrollment of 280 is above the median of 55 across 65 interventional studies indexed under Shoulder Injuries.

Browse Shoulder Injuries studies →

Lead sponsor

This is the only study on the registry with Zaans Medisch Centrum as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Aged18-65 years
  • Trauma \<48h

Exclusion criteria

Exclusion Criteria:

  • Any prior ipsilateral shoulder surgery.
  • Any diseases of the bones potentially influencing fracturability (osteogenesis imperfecta, osteoporosis, achondroplasia, M. Kahler, chronic (> 1yr) prednisone use > 5mg)
  • Any shoulder injury as part of a multi-trauma or high energy trauma (HET) with distractible injuries
  • Any condition that will influence the perception of pain (e.g. alcohol intoxication, psychiatric problems, mental retardation)
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
280 participants (estimated)

Study arms

  • Other
    MD as first examiner

    Patients will be examined according to a standardized physical examination item list

    Other: Standard diagnostic item list

  • Other
    Triage nurse as first examiner

    Patients will be examined according to a standardized physical examination item list

    Other: Standard diagnostic item list

Interventions

  • OtherStandard diagnostic item list

    All consecutive patients are assessed by both examiners, according to a standardized physical examination item list.

06

What researchers measure

Primary outcomes

  1. Diagnostic accuracy (sensitivity and specificity) of the clinical variables assessed with the score form.

    Time frame: An average of 12 to 18 months

Secondary outcomes

  1. Interobserver agreement for each clinical variable between both observers determined with the Cohen's kappa coefficient

    Time frame: An average of 12 to 18 months

07

Study locations

1 of 1 sites recruiting
  • Zaans Medisch Centrum
    Zaandam, Noord-Holland 1502 DV, Netherlands
    Recruiting
08

References and documents

Publications

  • Stiell IG, Greenberg GH, McKnight RD, Nair RC, McDowell I, Worthington JR. A study to develop clinical decision rules for the use of radiography in acute ankle injuries. Ann Emerg Med. 1992 Apr;21(4):384-90. doi: 10.1016/s0196-0644(05)82656-3. PubMed 1554175 ↗
  • Bachmann LM, Kolb E, Koller MT, Steurer J, ter Riet G. Accuracy of Ottawa ankle rules to exclude fractures of the ankle and mid-foot: systematic review. BMJ. 2003 Feb 22;326(7386):417. doi: 10.1136/bmj.326.7386.417. PubMed 12595378 ↗
  • Stiell I, Wells G, Laupacis A, Brison R, Verbeek R, Vandemheen K, Naylor CD. Multicentre trial to introduce the Ottawa ankle rules for use of radiography in acute ankle injuries. Multicentre Ankle Rule Study Group. BMJ. 1995 Sep 2;311(7005):594-7. doi: 10.1136/bmj.311.7005.594. PubMed 7663253 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 5, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02857439
Lead sponsor
Zaans Medisch Centrum
Responsible party
K. Rijsbergen (Research intern, Zaans Medisch Centrum) — Principal investigator
First posted
Aug 5, 2016
Start date
Jul 2016
Primary completion
Jul 2017 (estimated)
Completion
Jul 2018 (estimated)
Last update
Aug 5, 2016

Study contacts

Robert Jan Derksen, MD
Contact
Derksen.R@zaansmc.nl
Kim Rijsbergen, BSc
Contact
Rijsbergen.K@zaansmc.nl
Kim Rijsbergen, BSc
principal investigator
Robert Jan Derksen, MD
study director · Zaans Medisch Centrum

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion